Crossmark

Clinical and molecular characterization of POU3F4 mutations in multiple DFNX2 Chinese families

Crossref DOI link: https://doi.org/10.1186/s12881-018-0630-9

Published Online: 2018-09-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Su, Yu

Gao, Xue

Huang, Sha-Sha

Mao, Jing-Ning

Huang, Bang-Qing

Zhao, Jian-Dong

Kang, Dong-Yang

Zhang, Xin

Dai, Pu http://orcid.org/0000-0001-7007-912X
Funding

Funding for this research was provided by:

Medical science and technology innovation project (2015YW28)

Chinese National Nature Science Foundation Research Grant (81400471)

Project of the National Natural Science Foundation of China (81230020)

State 863 High Technology Key Project of China (2011AA02A112)

Minister of Science and Technology of China grant (2012BAI09B02)

Minister of Health of China grant (201202005)
License Information

Text and Data Mining valid from 2018-09-04
More Information

Article History

Received: 6 February 2017

Accepted: 21 June 2018

First Online: 4 September 2018

Ethics approval and consent to participate

: This study was approved by the Chinese PLA General Hospital Research Ethics Committee.

: Fully informed written consent for participation and publication of the clinical data was obtained from each subject or from the guardians of subjects < 18 years old.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.